Overview

The Use of Statins Following a Left Atrial Catheter Ablation Procedure to Prevent Atrial Fibrillation

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
To investigate whether statin therapy utilizing the drug Lipitor (atorvastatin) might be effective in preventing short-and long-term atrial fibrillation (AF) following a left atrial ablation procedure. We further hypothesize this reduction will result from diminished peri-procedural inflammation, which will be reflected in lower C-Reactive Protein (CRP) values in the blood.
Phase:
Phase 4
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
Pfizer
Treatments:
Atorvastatin
Atorvastatin Calcium